Flagship Harbor Advisors, LLC Novo Nordisk A S Transaction History

Flagship Harbor Advisors, LLC

$1.74 Billion
Q3 2024

A detailed history of Flagship Harbor Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Flagship Harbor Advisors, LLC holds 13,083 shares of NVO stock, worth $1.14 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

13,083

Previous 12,451 5.08%

Holding current value

$1.14 Million

Previous $1.6 Million 2.57%

% of portfolio

0.09%

Previous 0.1%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$119.07 - $145.42 $75,252 - $91,905	632 Added 5.08%	13,083 $1.56 Million
Q1 2024 Apr 16, 2024	BUY	$102.11 - $135.92 $59,325 - $78,969	581 Added 4.89%	12,451 $1.6 Million
Q4 2023 Jan 10, 2024	BUY	$87.78 - $105.45 $52,053 - $62,531	593 Added 5.26%	11,870 $1.23 Million
Q3 2023 Oct 17, 2023	BUY	$90.94 - $199.54 $582,743 - $1.28 Million	6,408 Added 131.61%	11,277 $1.03 Million
Q2 2023 Jul 11, 2023	BUY	$155.98 - $172.65 $202,929 - $224,617	1,301 Added 36.46%	4,869 $787,000
Q1 2023 Apr 12, 2023	BUY	$132.34 - $159.14 $29,511 - $35,488	223 Added 6.67%	3,568 $567,000
Q4 2022 Jan 13, 2023	SELL	$102.55 - $135.33 $21,227 - $28,013	-207 Reduced 5.83%	3,345 $0
Q3 2022 Oct 13, 2022	BUY	$95.28 - $116.93 $6,097 - $7,483	64 Added 1.83%	3,552 $354,000
Q2 2022 Jul 13, 2022	BUY	$103.24 - $121.81 $6,091 - $7,186	59 Added 1.72%	3,488 $389,000
Q1 2022 Apr 13, 2022	SELL	$93.1 - $112.54 $9,310 - $11,254	-100 Reduced 2.83%	3,429 $381,000
Q4 2021 Feb 10, 2022	BUY	$95.88 - $117.08 $98,085 - $119,772	1,023 Added 40.82%	3,529 $395,000
Q2 2021 Jul 26, 2021	BUY	$67.66 - $84.76 $169,555 - $212,408	2,506 New	2,506 $210,000
Q4 2020 Feb 08, 2021	SELL	$63.89 - $73.8 $132,571 - $153,135	-2,075 Closed	0 $0
Q3 2020 Oct 13, 2020	SELL	$63.69 - $70.22 $8,725 - $9,620	-137 Reduced 6.19%	2,075 $144,000
Q2 2020 Jul 31, 2020	BUY	$58.54 - $67.94 $83,068 - $96,406	1,419 Added 178.94%	2,212 $144,000
Q1 2020 May 12, 2020	BUY	$49.46 - $64.78 $3,808 - $4,988	77 Added 10.75%	793 $48,000
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $49 - $58	1 Added 0.14%	716 $41,000
Q3 2019 Oct 22, 2019	BUY	$47.54 - $53.43 $190 - $213	4 Added 0.56%	715 $37,000
Q2 2019 Jul 22, 2019	SELL	$46.79 - $52.47 $5,801 - $6,506	-124 Reduced 14.85%	711 $36,000
Q1 2019 Apr 15, 2019	SELL	$46.36 - $52.63 $5,795 - $6,578	-125 Reduced 13.02%	835 $43,000
Q4 2018 Jan 28, 2019	SELL	$41.54 - $47.25 $22,722 - $25,845	-547 Reduced 36.3%	960 $44,000
Q3 2018 Nov 05, 2018	BUY	$46.76 - $51.24 $327 - $358	7 Added 0.47%	1,507 $70,000
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $66,435 - $75,630	1,500 New	1,500 $69,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.

Account

Flagship Harbor Advisors, LLC Novo Nordisk A S Transaction History